Parallax Volatility Advisers, L.P. Tg Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $345,250 - $780,605	22,303 New	22,303 $554,000
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $174,261 - $496,692	-46,594 Reduced 91.65%	4,245 $18,000
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $397,052 - $1.04 Million	50,839 New	50,839 $483,000
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $358,917 - $838,497	-23,613 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $320,340 - $748,373	-21,075 Reduced 47.16%	23,613 $449,000
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $973,304 - $1.81 Million	44,688 New	44,688 $1.49 Million
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $159,407 - $208,023	3,831 New	3,831 $185,000
Q1 2021 May 14, 2021	SELL	$41.61 - $54.3 $159,407 - $208,023	-3,831 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $7,903 - $17,700	-1,107 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $69,834 - $153,361	-13,693 Reduced 92.52%	1,107 $12,000
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $59,495 - $118,991	14,800 New	14,800 $119,000
Q4 2018 Feb 14, 2019	SELL	$3.44 - $5.76 $120,351 - $201,519	-34,986 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $180,177 - $489,804	34,986 New	34,986 $196,000
Q1 2018 May 15, 2018	SELL	$8.7 - $16.8 $64,310 - $124,185	-7,392 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$7.35 - $12.3 $54,331 - $90,921	7,392	7,392 $61,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.